Angel Investing Statistics (2026)

Angel investors, wealthy individuals who back startups with their own money, put roughly $17.9 billion into US companies in 2024, the most recent full year measured by the UNH Center for Venture Research (CVR). That funded 55,346 ventures, making angels one of the largest sources of seed and early-stage capital in the country.

The 2024 total was down 3.1% from 2023, a much smaller drop than 2023's 16.4% slide. CVR calls 2024 a stable market: the number of angel deals barely changed while venture capital deals declined. Even so, angel dollars rival formal venture capital at the earliest stages, where traditional VC funds place well under 2% of their money.

CVR counted 445,535 active angel investors in 2024, meaning individuals who made at least one investment that year. That was up 5.5% from 422,350 in 2023, which had itself risen 14.8% from 367,945 in 2022. Total dollars fell in both years, so more angels wrote smaller checks.

The active count understates the pool. Inside angel groups, CVR found that roughly 47% of members were latent in 2022, joining but not investing that year. The population that could invest is far larger still (see the next section).

Most angel deals are private placements limited to accredited investors. The SEC's test, generally a net worth over $1 million excluding your home, or income above $200,000 ($300,000 with a spouse), gates who can legally participate in most raises.

Because those thresholds have never been indexed to inflation, the eligible pool has ballooned: over 24 million US households, about 18.5%, qualified in 2022, versus roughly 1.8% in 1983 (SEC). Actual active angels are a tiny fraction of that.

Angel dollars cycled between roughly $21 billion and $29 billion for a decade before the 2023 dip (see the chart and table below). The market peaked at $29.1 billion in 2021 during the startup boom, then fell to $22.3 billion in 2022, $18.6 billion in 2023 and $17.9 billion in 2024.

The number of funded ventures has drifted down from about 71,000 in 2015 to 54,735 in 2023 and 55,346 in 2024, even as the count of active angels rose. Fewer, more selective deals with more participants is the throughline of the recent retraction.

Nearly every headline metric fell in 2023 except the number of angels and the jobs each deal created (see the table below). Dollars dropped 16.4%, ventures funded fell 12.2%, and average valuations slid 7.9% to $3.5 million.

The bright spots: active angels rose 14.8%, and each angel investment was associated with 4.3 new jobs, up from 3.4 in 2022. CVR frames 2023 as a retraction year with an unusually strong showing from women angels.

2024 was steadier. Dollars fell 3.1% to $17.9 billion and deal size slipped 4.2%, while ventures funded held at 55,346, active angels grew 5.5% to 445,535 and each investment was tied to 4.1 jobs.

The most misread angel statistic is deal size. CVR's average of about $339,390 in 2023 is the total raised per venture from all angels in the round, not what one angel wrote. That figure was down 4.8% from $356,650 in 2022, and CVR reports deal size fell another 4.2% in 2024.

An individual angel's check is much smaller, typically about $25,000 to $100,000, with organized syndicates pooling into the $250,000-plus range (per-check range via industry aggregators, flagged as secondary). So one round of $339,390 might bundle several angels writing five-figure checks.

In 2023 angels received an average of 9.7% equity at a $3.5 million average valuation, so a typical deal traded roughly a tenth of the company for a few hundred thousand dollars. Equity was slightly higher than 2022's 9.3% because valuations fell.

Valuations had climbed steadily from 2018 through 2021, and CVR describes the 2022-2023 slide as a correction of that run-up. Lower valuations mean angels get more ownership per dollar, one of the few tailwinds in a down market.

Healthcare Services/Medical Devices led angel investing in 2024 at 29.5% of deals, followed by software at 20.2% (see the chart and table below). Biotech (15.5%) came next, then Industrial/Energy/Clean Tech (7.8%), retail (7.7%) and FinTech (6.2%).

The mix shifts year to year: software jumped from 16% of deals in 2022 to 25.1% in 2023 before easing to 20.2% in 2024. Biotech went from 5.1% of deals in 2023 to 15.5% in 2024, and FinTech fell from 12.9% to 6.2%. Angels rotate toward whichever sectors are producing fundable early-stage companies.

Angels are overwhelmingly early-stage. In 2024, 59% of deals were seed and start-up and another 20% were early stage (see the table below). Seed and start-up has been the leading stage for five straight years, and CVR notes the 2024 jump came while venture capital seed deals declined 16% from 2023 to 2024.

Expansion-stage deals fell sharply, from 35% of deals in 2022 to 18% in 2023 and 15% in 2024, which CVR reads as angels recommitting to the earliest and riskiest stage. In the Wiltbank data, 45% of funded companies had no revenue at all when they took the money.

The yield rate, the share of pitches that actually result in an investment, was 22.6% in 2024, after 24.2% in 2023 and 26.7% in 2022. In plain terms, a startup that gets in front of angels has slightly better than a 1 in 5 chance of landing a check.

CVR notes that yield rates in the 20% to 25% band historically signal a sustainable market. Women-led ventures cleared a higher bar: their 2024 yield rate was 26.7% (28.8% in 2023), above the overall market, which CVR reads as a sign of higher deal quality.

The most-cited returns research, Wiltbank and Boeker's study of 1,137 exits from 539 angels, found an average of 2.6x over 3.5 years, about a 27% IRR (see the table below). Wiltbank's later Tracking Angel Returns work found a similar 2.5x over 4.5 years, roughly 22%.

Individual angel groups have reported comparable figures: about 25% IRR at Tech Coast Angels and 31% at the Central Texas Angel Network. These are gross, pre-fee numbers and carry heavy survivorship bias, so treat them as ceilings, not expectations.

Angel returns are wildly skewed, and the averages hide it. In the Wiltbank data, 52% of all exits returned less than the capital invested, while just 7% returned more than 10x, and those few home runs produced 75% of all the dollars returned (see the chart below).

At Tech Coast Angels, 8 companies (about 3% of outcomes) generated 77% of all proceeds. The lesson is portfolio math: a single angel bet most likely loses money, so returns depend on making enough investments to catch a rare outlier.

The fastest-moving story in the recent data is women. Women rose from 33.6% of active angels in 2021 to 46.7% in 2023, then fell back to 39.1% in 2024. Women-owned ventures went from 28.6% of pitches in 2021 to 46.3% in 2023 and 40.2% in 2024 (see the table below).

Minority participation is thinner and choppy: minority angels were 7.1% of investors in 2024 (5.7% in 2023, 8.6% in 2022) and minority-owned firms were 9.4% of pitches, though their 32.4% yield rate outran the overall market, suggesting strong but underrepresented deal flow.

Angel investing offers high potential returns but concentrated, illiquid risk: more than half of individual bets lose money, exits take years, and you generally must be accredited to participate. The historical 20%-plus IRRs come only from diversified portfolios that catch the rare 10x winner, not from picking one startup.

For most investors, angel deals are a small satellite around a diversified core of public stocks and funds, not a substitute for it. If you do explore private deals, spread capital across many companies, expect long holds, and size the whole allocation to what you can afford to lose entirely.